The "Liraglutide and Semaglutide - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Liraglutide and Semaglutide was valued at US$17.1 ...
Altimmune ($ALT) announced an update on their ongoing clinical study. Altimmune’s IMPACT trial, officially titled “A Phase 2, Multicenter, ...
Gold nanoparticles that cluster in response to T cell enzymes can predict cancer immunotherapy success days before tumors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback